For IL-8 the median serum level for patients with adenomas (19.97 ng/mL) was also lower than the levels observed in all patients with invasive carcinoma (27.46 ng/mL) and in all healthy controls (20.74 ng/mL, both P > 0.05). The gene discussed is CXCL8; the disease is invasive carcinoma.